Oxcarbazepine in patients with impulsive aggression: A double-blind, placebo-controlled trial

Journal of Clinical Psychopharmacology

Volumn 25, Issue 6, 2005, Pages 575-579

  Mattes, Jeffrey A ^a  

^a Psychopharmacology Research Association of Princeton   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXCARBAZEPINE; PLACEBO;

ADULT; AGGRESSION; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPONATREMIA; IMPULSIVENESS; MALE; MENTAL DISEASE; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AGGRESSION; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; SELF ASSESSMENT (PSYCHOLOGY); TREATMENT OUTCOME;

EID: 27944491215     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000186739.22395.6b     Document Type: Article

References (19)

1. Posternak MA, Zimmerman M. Anger and aggression in psychiatric outpatients. J Clin Psychiatry. August 2002;63:665-672.
2. Mattes JA. Intermittent explosive disorder: DSM-IV vs. modified criteria. Usefulness in treatment studies of impulsive aggression. Presented as a poster at the 43rd NCDEU Annual Meeting; May 27-30, 2003; Boca Raton, Fla.
3. Olvera RL. Intermittent explosive disorder. CNS Drugs. 2002;16:517-526.
4. Barratt ES. The use of anticonvulsants in aggression and violence. Psychopharmacol Bull. 1993;29:75-81.
5. Lion J. Conceptual issues in the use of drugs for the treatment of aggression in man. J Nerv Ment Dis. 1975;160:76-82.
6. Sheard MH. Review - clinical pharmacology of aggressive behavior. Clin Neuropharmacol. 1984;7:173-183.
7. Mattes JA. Psychopharmacology of temper outbursts: a review. J Nerv Ment Dis. 1986;174:464-470.
8. De Vogelaer J. Carbamazepine in the treatment of psychotic and behavioral disorders: a pilot study. ACTA Psychiatr Belg. 1981;81:532-541.
9. Cueva JE, Overall JE, Small AM, et al. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1996;35:480-490.
10. Young AL, Hillbrand M. Carbamazepine lowers aggression: a review. Bull Am Acad Psychiatry Law. 1994;22:52-61.
11. Kavoussi RJ, Coccaro EF. Divalproex sodium for impulsive-aggressive behavior in patients with personality disorder. J Clin Psychiatry. 1998;59:676-680.
12. Hollander E, Tracy KA, Swann AC, et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology. 2003;28:1186-1197.
13. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder [revision]. Am J Psychiatry. 2002;159(April suppl):4-5, 9-10, 24.
14. Coccaro EF, Kavoussi RJ, Berman ME, et al. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry. 1998;39:368-376.
15. Coccaro EF. Intermittent explosive disorder. Curr Psychiatry Rep. 2000;2:67-71.
16. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al. Development of neuropharmacologically based behavior assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci. 1991;3:544-551.
17. Lyerly SB. Handbook of Psychiatric Rating Scales. 2nd ed. Rockville, MD: National Institute of Mental Health; 1973:8.
18. McNemar Q. Psychological Statistics. New York, NY: Wiley; 1969:428.
19. Fleiss J. The Design and Analysis of Clinical Experiments. New York, NY: Wiley; 1986:186-219.